BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 951 filers reported holding BAXTER INTL INC in Q2 2014. The put-call ratio across all filers is 0.79 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $50,146,000 | -0.4% | 799,135 | -3.9% | 0.20% | -2.5% |
Q2 2017 | $50,336,000 | +2.2% | 831,444 | -12.5% | 0.20% | +2.0% |
Q1 2017 | $49,269,000 | +14.5% | 950,036 | -2.1% | 0.20% | +10.6% |
Q4 2016 | $43,043,000 | -23.5% | 970,746 | -17.9% | 0.18% | -23.8% |
Q3 2016 | $56,270,000 | -6.3% | 1,182,152 | -10.9% | 0.24% | -9.6% |
Q2 2016 | $60,028,000 | +21.4% | 1,327,465 | +10.2% | 0.26% | +20.9% |
Q1 2016 | $49,451,000 | +245.5% | 1,204,376 | +221.0% | 0.22% | +252.5% |
Q4 2015 | $14,313,000 | +76.6% | 375,174 | +52.1% | 0.06% | +69.4% |
Q3 2015 | $8,105,000 | -64.3% | 246,728 | -23.9% | 0.04% | -61.3% |
Q2 2015 | $22,675,000 | +6.8% | 324,257 | +4.6% | 0.09% | +8.1% |
Q1 2015 | $21,234,000 | -31.5% | 309,987 | -26.7% | 0.09% | -35.3% |
Q4 2014 | $31,010,000 | +1.8% | 423,117 | -0.3% | 0.13% | +3.1% |
Q3 2014 | $30,460,000 | -4.0% | 424,407 | -3.3% | 0.13% | 0.0% |
Q2 2014 | $31,731,000 | -15.1% | 438,876 | -18.3% | 0.13% | -16.8% |
Q4 2013 | $37,353,000 | +11.0% | 537,060 | +4.9% | 0.16% | +2.6% |
Q3 2013 | $33,647,000 | +14.4% | 512,215 | +20.7% | 0.15% | -2.6% |
Q2 2013 | $29,408,000 | – | 424,536 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |